Product Images Cisatracurium Besylate

This appears to be a chart or graph representing data for a certain period of time. It shows a percentage increase of 60% over a 4-hour period and has the label "MAP" at the top. The other two lines on the graph appear to have a similar increase of around 60%. However, without more context, it is difficult to determine the exact meaning and interpretation of the data presented.*

The given text is not clear and contains just a few mathematical symbols without any context and explanation. Hence, a useful description cannot be generated. It is not-available.*

This is a warning about the prescription drug Cisatracurium Besylate, which is a paralyzing agent. It may cause respiratory arrest, and facilities for immediate intervention should be available. This injection is torpytogenic and should only be administered intravenously. The usual dosage should be noted by the package insert. The drug comes in a single-dose vial, diluted by Berkley Heights. Lot and expiration information is also provided.*

Cisatracurium Besylate Injection USP is a paralyzing agent that causes respiratory distress. It contains benzmasulons 6 and is recommended for immediate use in case of facial spasms. This medication is available in single doses, and it is important to use it within 21 days after refrigeration. The injection is for intravenous use only, and the packaging contains dosage information and prescribing information. Store at 2° to 8°C and discard any unused portion. The manufacturer of this medication is Hikma, and the product is produced in Portugal.*

This text provides product identification and tracking information including the GTIN (Global Trade Identification Number) code, serial number, expiration date, and lot number. It is commonly used in industries where traceability and quality control are critical, such as pharmaceuticals or food production.*